Vertigo, a common clinical syndrome characterized by the sensation of spinning or a feeling of movement when stationary, is a complex condition that often challenges clinicians. A comprehensive approach is essential for accurate diagnosis and effective management.
Vertigo, often associated with vestibular disorders, is not a disease itself but a symptom of various underlying conditions. It is crucial to differentiate it from non-vestibular dizziness for appropriate treatment.
A detailed patient history is the cornerstone of vertigo diagnosis. The onset, duration, triggers, and associated symptoms can provide valuable insights. Physical examination, including bedside vestibular tests, can further aid in localizing the lesion. Investigations such as audiometry, vestibular evoked myogenic potentials (VEMP), and imaging may be required based on clinical suspicion.
Management of vertigo is tailored based on the underlying cause. Acute vertigo due to vestibular neuritis can be managed with vestibular suppressants, while benign paroxysmal positional vertigo (BPPV) can be treated with repositioning maneuvers. Chronic vertigo conditions like Ménière's disease may require long-term strategies including dietary modifications, diuretics, and vestibular rehabilitation.
Vestibular rehabilitation, an exercise-based program, is an integral part of vertigo management. It aims to promote central nervous system compensation for inner ear deficits. It includes habituation exercises, gaze stabilization exercises, and balance training.
Vertigo is a multifaceted symptom requiring a comprehensive clinical approach for successful diagnosis and management. A thorough understanding of the underlying mechanisms, a systematic diagnostic approach, and a patient-specific management plan are key to improving patient outcomes and quality of life.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation